Cargando…
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study
BACKGROUND: Acute coronary syndrome (ACS) is a leading cause of mortality and morbidity in Qatar and globally. AIM: The primary objective of the study was to evaluate the effectiveness of a structured clinical pharmacist-delivered intervention on all-cause hospitalizations and cardiac-related readmi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250427/ https://www.ncbi.nlm.nih.gov/pubmed/36795303 http://dx.doi.org/10.1007/s11096-023-01538-4 |
_version_ | 1785055752248885248 |
---|---|
author | El Hajj, Maguy Saffouh Kaddoura, Rasha Abu Yousef, Safae E. A. Orabi, Bassant Awaisu, Ahmed AlYafei, Sumaya Shami, Rula Mahfoud, Ziyad R. |
author_facet | El Hajj, Maguy Saffouh Kaddoura, Rasha Abu Yousef, Safae E. A. Orabi, Bassant Awaisu, Ahmed AlYafei, Sumaya Shami, Rula Mahfoud, Ziyad R. |
author_sort | El Hajj, Maguy Saffouh |
collection | PubMed |
description | BACKGROUND: Acute coronary syndrome (ACS) is a leading cause of mortality and morbidity in Qatar and globally. AIM: The primary objective of the study was to evaluate the effectiveness of a structured clinical pharmacist-delivered intervention on all-cause hospitalizations and cardiac-related readmissions in patients with ACS. METHOD: A prospective quasi-experimental study was conducted at Heart Hospital in Qatar. Discharged ACS patients were allocated to one of three study arms: (1) an intervention group (received a structured clinical pharmacist-delivered medication reconciliation and counselling at discharge, and two follow-up sessions at 4 weeks and 8 weeks post-discharge), (2) a usual care group (received the general usual care at discharge by clinical pharmacists) or, (3) a control group (discharged during weekends or after clinical pharmacists' working hours). Follow-up sessions for the intervention group were designed to re-educate and counsel patients about their medications, remind them about the importance of medication adherence, and answer any questions they may have. At the hospital, patients were allocated into one of the three groups based on intrinsic and natural allocation procedures. Recruitment of patients took place between March 2016 and December 2017. Data were analyzed based on intention-to-treat principles. RESULTS: Three hundred seventy-three patients were enrolled in the study (intervention = 111, usual care = 120, control = 142). Unadjusted results showed that the odds of 6-month all-cause hospitalizations were significantly higher among the usual care (OR 2.034; 95% CI: 1.103–3.748, p = 0.023) and the control arms (OR 2.704; 95% CI: 1.456–5.022, p = 0.002) when compared to the intervention arm. Similarly, patients in the usual care arm (OR 2.304; 95% CI: 1.122–4.730, p = 0.023) and the control arm (OR 3.678; 95% CI: 1.802–7.506, p ≤ 0.001) had greater likelihood of cardiac-related readmissions at 6 months. After adjustment, these reductions were only significant for cardiac-related readmissions between control and intervention groups (OR 2.428; 95% CI: 1.116–5.282, p = 0.025). CONCLUSION: This study demonstrated the impact of a structured intervention by clinical pharmacists on cardiac-related readmissions at 6 months post-discharge in patients post-ACS. The impact of the intervention on all-cause hospitalization was not significant after adjustment for potential confounders. Large cost‐effective studies are required to determine the sustained impact of structured clinical pharmacist-provided interventions in ACS setting. TRIAL REGISTRATION: Clinical Trials: NCT02648243 Registration date: January 7, 2016. |
format | Online Article Text |
id | pubmed-10250427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102504272023-06-10 Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study El Hajj, Maguy Saffouh Kaddoura, Rasha Abu Yousef, Safae E. A. Orabi, Bassant Awaisu, Ahmed AlYafei, Sumaya Shami, Rula Mahfoud, Ziyad R. Int J Clin Pharm Research Article BACKGROUND: Acute coronary syndrome (ACS) is a leading cause of mortality and morbidity in Qatar and globally. AIM: The primary objective of the study was to evaluate the effectiveness of a structured clinical pharmacist-delivered intervention on all-cause hospitalizations and cardiac-related readmissions in patients with ACS. METHOD: A prospective quasi-experimental study was conducted at Heart Hospital in Qatar. Discharged ACS patients were allocated to one of three study arms: (1) an intervention group (received a structured clinical pharmacist-delivered medication reconciliation and counselling at discharge, and two follow-up sessions at 4 weeks and 8 weeks post-discharge), (2) a usual care group (received the general usual care at discharge by clinical pharmacists) or, (3) a control group (discharged during weekends or after clinical pharmacists' working hours). Follow-up sessions for the intervention group were designed to re-educate and counsel patients about their medications, remind them about the importance of medication adherence, and answer any questions they may have. At the hospital, patients were allocated into one of the three groups based on intrinsic and natural allocation procedures. Recruitment of patients took place between March 2016 and December 2017. Data were analyzed based on intention-to-treat principles. RESULTS: Three hundred seventy-three patients were enrolled in the study (intervention = 111, usual care = 120, control = 142). Unadjusted results showed that the odds of 6-month all-cause hospitalizations were significantly higher among the usual care (OR 2.034; 95% CI: 1.103–3.748, p = 0.023) and the control arms (OR 2.704; 95% CI: 1.456–5.022, p = 0.002) when compared to the intervention arm. Similarly, patients in the usual care arm (OR 2.304; 95% CI: 1.122–4.730, p = 0.023) and the control arm (OR 3.678; 95% CI: 1.802–7.506, p ≤ 0.001) had greater likelihood of cardiac-related readmissions at 6 months. After adjustment, these reductions were only significant for cardiac-related readmissions between control and intervention groups (OR 2.428; 95% CI: 1.116–5.282, p = 0.025). CONCLUSION: This study demonstrated the impact of a structured intervention by clinical pharmacists on cardiac-related readmissions at 6 months post-discharge in patients post-ACS. The impact of the intervention on all-cause hospitalization was not significant after adjustment for potential confounders. Large cost‐effective studies are required to determine the sustained impact of structured clinical pharmacist-provided interventions in ACS setting. TRIAL REGISTRATION: Clinical Trials: NCT02648243 Registration date: January 7, 2016. Springer International Publishing 2023-02-16 2023 /pmc/articles/PMC10250427/ /pubmed/36795303 http://dx.doi.org/10.1007/s11096-023-01538-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article El Hajj, Maguy Saffouh Kaddoura, Rasha Abu Yousef, Safae E. A. Orabi, Bassant Awaisu, Ahmed AlYafei, Sumaya Shami, Rula Mahfoud, Ziyad R. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
title | Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
title_full | Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
title_fullStr | Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
title_full_unstemmed | Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
title_short | Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
title_sort | effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250427/ https://www.ncbi.nlm.nih.gov/pubmed/36795303 http://dx.doi.org/10.1007/s11096-023-01538-4 |
work_keys_str_mv | AT elhajjmaguysaffouh effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT kaddourarasha effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT abuyousefsafaeea effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT orabibassant effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT awaisuahmed effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT alyafeisumaya effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT shamirula effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy AT mahfoudziyadr effectivenessofastructuredpharmacistdeliveredinterventionforpatientspostacutecoronarysyndromesonallcausehospitalizationsandcardiacrelatedhospitalreadmissionsaprospectivequasiexperimentalstudy |